Transdermal contraceptive formulations, methods and devices
US5376377A · kind A · utility
44Cited by
18References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1992 |
| Grant date | Dec 27, 1994 |
| Priority date | — |
| Expiry date | Dec 17, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods for the transdermal administration of a contraceptively effective amount of gestodene and an estrogen, such as ethinyl estradiol, in combination, together with a suitable permeation enhancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.